Skip to main content
SpringerLink
Log in

New Pharmaceutical Forms for Skin Protection

  • Chapter
NBC Risks Current Capabilities and Future Perspectives for Protection

Part of the book series: NATO Science Series ((ASDT,volume 25))

  • 186 Accesses

Abstract

New drug development has grown to expensive and time-consuming dimensions. This is a reason for re-evaluation of presently used drugs and their forms and for seeking new technological ways of enhancing bioavailability and regulating effects to prepare the drugs of second and third generation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Niedner, R. (1998) Transdermale Therapeutische Systeme, Hautarzt 39, 761–766.

    Google Scholar 

  2. Karzel, K. and Liedtke, R.K. (1990) Vor-und Nachteil der transkutaner Arzneimittel-therapie, Dtsch. Apoth. Ztg. 130, 631.

    Google Scholar 

  3. Mutschier, E. and Langguth, P. (1987) Transdermale Therapeutusche Systeme, Fortschr. Med. 105, 571–574.

    Google Scholar 

  4. Gorth, H., Spuler, A. and Vetter, W. (1988) Transdermale Therapeutische Systeme, Dtsch. Med. Wschr. 113, 819–821.

    Article  Google Scholar 

  5. Knoch, A. and Merkle, H.P. (1987) Polymer-laminate zur transdermalen Freigabe, Acta Pharm. Technol. 33, 195–201.

    CAS  Google Scholar 

  6. Neubert, R., Winter, K. and Bendas, B. (1993) Bestimmung der ArzneistoffVerfugbarkeit aus kommerziellen topischen Zubereintungen mit dem Mehrschichtmembranenmodell, Pharmazie 48, 54–56.

    PubMed  CAS  Google Scholar 

  7. Lippold, B.C. (1987) Choice of lipophilic polymer material for transdermal therapeutic system and control of release, Pharm. Ind. 49, 1295–1300.

    CAS  Google Scholar 

  8. Boddé, H.E., Van Aalten, E.A.C. and Junginger, H.E. (1989) Hydrogel patches for transdermal drug delivery, J. Pharm. Pharmacol. 41, 52–155.

    Article  Google Scholar 

  9. Knoch, A. and Merkle, H.P. (1987) Polymer-laminate zur transdermalen Freigabe II, Acta Pharm. Technol. 33, 202–207.

    CAS  Google Scholar 

  10. Ducková, K. and Kučera, J. (1989) K niektorým otázkam transdermálnej aplikácie liekov, Farm. Obzor 58, 489–498.

    Google Scholar 

  11. Pflegel, P. and Dittgen, M. (1987) Arzneimittel und Organismus. Transdermale Therapeutische Systeme, Pharmazie 42, 799–809.

    PubMed  CAS  Google Scholar 

  12. Asthon, P., Hadgraft, J. and Walters, K.A. (1986) Effects of surfactants in percutaneous absorption, Acta Pharm. Helv. 61, 228–235.

    Google Scholar 

  13. Cooper, E. R. and Berner B. (1987) Transdermal delivery of drugs, CRC Press, Boca Raton, Fla.

    Google Scholar 

  14. Woodford, R. and Barry, B.W.J. (1986) Toxicol., Cut. Ocular Toxicol. 5, 167.

    Article  Google Scholar 

  15. Řehula, M. (1991) Vliv některých přísad na farmaceutickou dostupnost atropinu, Českoslov. Farm. 40, 230–233.

    Google Scholar 

  16. Kasting, G.B., Francis, W.R. and Roberts, G.E. (1993) Skin penetration enhancement of triprolidine base by propylenglycol, J. Pharm. Sci. 82, 551–552.

    Article  PubMed  CAS  Google Scholar 

  17. Cooper, E.R. (1984) J. Pharm. Sci. 73, 1153.

    Article  PubMed  CAS  Google Scholar 

  18. Wearly, L. and Chicen, Y.W. (1990) Enhancement of the in vitro skin permeability of azidothymidine via ionophoresis and chemical enhancer. Phar. Res. 7, 34–40.

    Article  Google Scholar 

  19. Wiechers, J.W., Drenth, B.F., Jonkman, J.H. and de Zeeuw, R.A. (1990) Percutaneous absorption metabolic profiling and excretion of the penetration enhancer Azone after multiple dosing of an Azone containing triamcinolone acetonide cream in humans, J. Pharm. Sci. 79, 111–115.

    Article  PubMed  CAS  Google Scholar 

  20. Okamoto, H., Hashida, M. and Sezaki, H. (1991) Effect of 1-alkyl or 1-alkenylazacyloalkanole derivates on the penetration of drugs with differen lipophilicities through guinea pig skin. J. Pharm. Sci. 80, 64–68.

    Article  Google Scholar 

  21. Chalabala, M., Burelová, A. and Ducková, K. (1987) Nosiče léčiv pro cílovou terapii. I. Lipidové vezikuly, Českoslov. Farm. 5, 229–233.

    Google Scholar 

  22. Purmann, T., Mentrup, E. and Kreuter, J. (1993) Reparation of SUV-liposomes by high-pressure homogenisation, Eur. J. Pharm. Biopharm. 39, 45–52.

    CAS  Google Scholar 

  23. Allen, T.M., McAllisters, L., Mausolf, S. and Gyorffy, E. (1981) Liposome-cells interactions, Biochim. Biophys. Acta 643, 346–362.

    Article  PubMed  CAS  Google Scholar 

  24. Rhaman, Y.E., Cerny, E.A. and Lan, E.H. (1983) Enhanced iron removal from liver parenchymal cells in experimental iron overload. Liposomes encapsulation of HBED and phenobarbital administration, Blood 62, 209–213.

    Google Scholar 

  25. Rhaman, Y.E., Cerny, E.A. and Patel, K.R. (1982) Differential uptake of liposomes varying in size and lipid composition by parenchymal and Kupfer cells of mouse liver, Life Sci. 31, 2061–2071.

    Article  Google Scholar 

  26. Michael, C., Purmann, T., Mentrup, E., Seiller E., and Kreuter J. (1992) Effect of liposomes on percutaneous penetration of lipophilic material, Int. J. Pharm. 84, 93–105.

    Article  Google Scholar 

  27. Plestis, J., Ramechandran, C., Weiner, N. and Muller, D. (1994) The influence of particle size of liposomes on the deposition of drug into skin, Int. J. Pharm. 103, 277–282.

    Article  Google Scholar 

  28. Zeng, S., Yun, G.X. and Hu, C.Z. (1993) Intravitreal pharmacokinetics of liposome-encapsulated amikacin in rabbit model, Ophtalmology 100, 1640–1644.

    CAS  Google Scholar 

  29. Singh, K. and Mezei, M. (1984) Liposomal ophthalmic drug delivery system, Int. J. Pharm. 19, 293–269.

    Article  Google Scholar 

  30. Stratford, R.E., Yang, D.C., Redel, M.A. and Lee V.H. (1983) Effects of topically applied liposomes on disposition of epinephrine and inulin in the albino rabbit eye, Int. J. Pharm. 13, 263–272.

    Article  CAS  Google Scholar 

  31. Mezei, M. (1991) Delivering the goods: Canadian, Pharm. J. 124, 132–134,136,140,155.

    Google Scholar 

  32. Krowczynski, L. and Stoszek, T. (1984) Liposomes as drug carriers in the transdermal therapy, Pharmazie 39, 627–629.

    PubMed  CAS  Google Scholar 

  33. Wohlrab W., Lasch J., Taube K.M. and Wozniak K.D. (1989) Skin permeation of liposomal incorporated hydrocortisone, Pharmazie 44, 333–335.

    PubMed  CAS  Google Scholar 

  34. Schafer-Korting M. and Korting H.C. (1989) Liposome preparations — A step forward in topical drug therapy for skin disease? J. Am. Acad. Dermatol. 21, 1271–1275.

    Article  PubMed  CAS  Google Scholar 

  35. Weiner N. and Williams N. (1989) Topical delivery of liposomally encapsulated interferon evaluated in a cutaneous herpes guinea pig model, Antimicrob. Agents Chemother. 33, 1219–1221.

    Article  Google Scholar 

  36. Foldvari M. And Geszets A. (1990) Cutaneous penetration of drugs by liposomal drug delivery system. J. Microencapsulation 7, 479.

    Article  PubMed  CAS  Google Scholar 

  37. Gabrijelčič V. And Šentjurc M. (1995) Influence of hydrogels on liposome stability and on the transport of liposome entrapped substances into the skin, Int. J. Pharm. 118, 207–212.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Pharmacy, Commenius University, Bratislava, Slovak Republic

    K. Ducková & V. Koprda

  2. Faculty of Chemical Technology, Slovak Technical University, Bratislava, Slovak Republic

    V. Koprda

Authors
  1. K. Ducková
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Koprda
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Studies and Science, German Armed Forces Medical Academy, Munich, Germany

    Torsten Sohns  & Harald Kempf  & 

  2. University of Medicine & Pharmacy ”Carol Davila”, Bucharest, Romania

    Victor A. Voicu

  3. Department of Studies and Science, Institute of Pharmacology and Toxicology, German Armed Forces Medical Academy, Munich, Germany

    Ladislaus Szinicz

  4. Department of Studies and Science, Institute of Microbiology, German Armed Forces Medical Academy, Munich, Germany

    Ernst-Juergen Finke

  5. Army Center of Medical Research and University of Medicine and Pharmacy „Carol Davila“, Bucharest, Romania

    Constantin Mircioiu

  6. Defence Research Establishment Suffield, Box 4000, Medicine Hat, Alberta, TIB 2 P5, Canada

    P. Lundy

  7. An-Ex, Redwood Building, Cf 1 3xF, Cardiff, UK

    Keith R. Brain

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Ducková, K., Koprda, V. (1999). New Pharmaceutical Forms for Skin Protection. In: Sohns, T., et al. NBC Risks Current Capabilities and Future Perspectives for Protection. NATO Science Series, vol 25. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4641-8_29

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-4641-8_29

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-0-7923-5803-9

  • Online ISBN: 978-94-011-4641-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation